Correlative study to assess the predictive power of the ICOS HF calculator in the prediction of development of HER-2 antagonist induced cardiac dysfunction in a single center in Saudi Arabia in 2023

Back

ESC Professional Premium Access

Correlative study to assess the predictive power of the ICOS HF calculator in the prediction of development of HER-2 antagonist induced cardiac dysfunction in a single center in Saudi Arabia in 2023

Session: Cardiovascular risk of cancer therapy

Topic: Cardio-Oncology

Speaker: Doctor M. Al Qaseer (Dammam, SA)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Maryam Al Qaseer

King Fahad Specialist Hospital, Dammam (Saudi Arabia)

1 presentation

0 follower

5 more presentations in this session

Artificial intelligence applied to electrocardiographic images for the risk stratification of cancer therapeutics-related cardiac dysfunction

Speaker: Doctor E. Oikonomou (New Haven, US)

Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry

Speaker: Doctor B. Huang (Chongqing, CN)

Immune-checkpoint myocarditis phenotype when using systematic troponin surveillance in cancer patients.

Speaker: Doctor F. Cribari (Rome, IT)

Angiotensin II as a linking factor in cardiovascular disease enhanced cancer growth

Speaker: Mr B. Van Berlo (Antwerp, BE)

Transcatheter mitral edge-to-edge repair in patients with prior cancer diagnosis

Speaker: Doctor R. Gonzalez-Manzanares (Cordoba, ES)

Access the full session

Cardiovascular risk of cancer therapy

Speakers: Doctor M. Al Qaseer, Doctor E. Oikonomou, Doctor B. Huang, Doctor F. Cribari, Mr B. Van Berlo...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources